Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Small Cell Lung Carcinoma 46Lymphoma, Large B-Cell, Diffuse 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Lung Neoplasms 21Leukemia, Myeloid, Acute 20Burkitt Lymphoma 18Hodgkin Disease 15Recurrence 14Lymphoma, Non-Hodgkin 14Lymphoma 14Carcinoma, Non-Small-Cell Lung 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Neuroblastoma 10Lymphoma, Mantle-Cell 10Lymphoma, B-Cell 10Leukemia 10Medulloblastoma 8Neoplasms, Germ Cell and Embryonal 7Neoplasms 7Lymphoma, Follicular 7Multiple Myeloma 6Lymphoma, T-Cell 6Brain Neoplasms 6Sarcoma, Ewing 5Retinoblastoma 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Immunoblastic Lymphadenopathy 5Ependymoma 5Sarcoma 4Rhabdomyosarcoma 4

Interventions

pomalidomide 2liposomal doxorubicin 2plerixafor 1abemaciclib 1Watchful Waiting 1Vincristine 1Transurethral Resection of Prostate 1Self Care 1Rituximab 1Proctoscopy 1Prednisone 1Paclitaxel 1Nivolumab 1Maraviroc 1Human Papillomavirus Recombinant Vaccine nonavalent 1Focus Groups 1Fluorouracil 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Colposcopy 1Blood Specimen Collection 1Benzethonium 1Anti-HIV Agents 1Amyloid 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Etoposide × 1 year × Clear all
NCT00006436 2025-12-30

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
68 enrolled 24 charts
Lymphoid

Acquired Immunodeficiency Syndrome, Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related

Data powered by HemOnc (CC BY 4.0) Colophon âš¡